About Orflo
Orflo is a company based in Ketchum (United States) founded in 2003 was acquired by Gemini Bio in November 2019. Orflo has raised $4.36 million across 3 funding rounds from investors including Gemini Bio, Broadoak Capital Partners and Research Corporation Technologies. Orflo offers products and services including Moxi GO II, Moxi V, and Moxi Z. Orflo operates in a competitive market with competitors including Cytek Biosciences, ACEA Biosciences, Accuri Cytometers, IntelliCyt and Cyntellect, among others.
- Headquarter Ketchum, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4.36 M (USD)
in 3 rounds
-
Latest Funding Round
$175 K (USD), Series A
Apr 06, 2017
-
Investors
Gemini Bio
& 2 more
-
Employee Count
Not available
-
Acquired by
Gemini Bio
(Nov 11, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Orflo
Orflo offers a comprehensive portfolio of products and services, including Moxi GO II, Moxi V, and Moxi Z.
Mini device for accurate cell counting and fluorescence detection.
Tool for precise cell count, size, and viability measurements.
Compact system for reliable cell counting in research.
Funding Insights of Orflo
Orflo has successfully raised a total of $4.36M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $175 thousand completed in April 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Orflo
Orflo has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Gemini Bio, Broadoak Capital Partners and Research Corporation Technologies.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Research Corporation Technologies is engaged in licensing biomedical technologies.
|
Locked | Locked | Locked | |
|
Investment banking services are offered in the United States.
|
Locked | Locked | Locked | |
|
Supplement reagents for cell and gene therapy are manufactured.
|
Locked | Locked | Locked |
Investor details for Orflo
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Orflo
Investment portfolio details for Orflo
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Orflo
Detailed financials for Orflo
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Orflo Comparisons
Peer comparison for Orflo
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Orflo
Orflo operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cytek Biosciences, ACEA Biosciences, Accuri Cytometers, IntelliCyt and Cyntellect, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Advanced flow cytometry systems are manufactured for research applications.
|
|
| Locked | Locked | Locked |
Instruments for life science research are developed and marketed.
|
|
| Locked | Locked | Locked |
Compact flow cytometers for cell analysis are developed and provided.
|
|
| Locked | Locked | Locked |
Screening solutions are provided using bead-based and cell-based assays.
|
|
| Locked | Locked | Locked |
Offers technology for cell analysis, purification, and processing.
|
Detailed competitors of Orflo
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Orflo
Complete news archive for Orflo
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Orflo
Orflo was founded in 2003 and raised its 1st funding round 10 years after it was founded.
Orflo is headquartered in Ketchum, United States. It is registered at Ketchum, Idaho, United States.
Orflo is a funded company, having raised a total of $4.36M across 3 funding rounds to date.
Orflo Technologies is developing and marketing instrumentation for the cell and protein analysis. Orflos instrumentation is a patent protected µFlow Cell Cassette. Through the combination of impedance (Coulter Principle) and fluorescence based flow cytometry Orflos instruments provide cell analysis by directly measuring fluorescence and cell volume simultaneously. The first product developed by Orflo is a hand-held cell counter. Later, Orflo extended single use cell counting to flow cytometry and multiplex bead-based assays for cell and protein research. After that, Moxi Flow and zEPI Flow platforms are launched which provides better cell and protein analysis; apoptosis, multiplexedflow cytometry, viability, RFP transfection efficiency checks, cell cycle, phagocytosis, multiplexed cytokine analysis.
Orflo's top competitors include Cytek Biosciences, Bioaffinity technologies and Accuri Cytometers.
Orflo offers Moxi GO II, Moxi V, and Moxi Z.
Orflo has 3 investors. Key investors include Gemini Bio, Broadoak Capital Partners, and Research Corporation Technologies.